. 2018 Jun 26;9(3):85–90. doi: 10.14740/wjon1097w

Table 3. Univariate and Multivariate Analyses.

	Univariate				Multivariate
	Hazard ratio	P value	95% CI		Hazard ratio	P value	95% CI
	Hazard ratio	P value	Lower	Upper	Hazard ratio	P value	Lower	Upper
Age	0.755	0.235	0.461	1.193
Gender	0.329	< 0.001	0.204	0.514	0.367	0.003	0.183	0.717
Smoking status	0.349	< 0.001	0.215	0.549	0.696	0.323	0.344	1.435
Histology	0.250	< 0.001	0.165	0.382	0.439	0.001	0.271	0.715
pT status	0.450	< 0.001	0.298	0.683	0.958	0.866	0.590	1.580
pN status	0.330	< 0.001	0.211	0.534	0.409	0.002	0.242	0.704
CEA	0.382	< 0.001	0.252	0.586	0.446	0.001	0.287	0.702
CYFRA21-1	0.353	< 0.001	0.229	0.556	0.835	0.502	0.501	1.428
GPS	0.409	< 0.001	0.265	0.622	0.499	0.009	0.296	0.838
NLR	0.309	0.003	0.168	0.635	0.963	0.922	0.472	2.139
PLR	0.462	< 0.001	0.306	0.698	0.834	0.532	0.471	1.473
PNI	0.599	0.017	0.396	0.910	0.772	0.346	0.449	1.323
SII	0.368	< 0.001	0.241	0.556	0.927	0.841	0.444	1.920
ALI	0.312	< 0.001	0.204	0.473	0.444	0.026	0.217	0.907

GPS: Glasgow prognostic score; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; PNI: prognostic nutritional index; SII: systemic immune-inflammation index; ALI: advance lung cancer inflammation index; CEA: carcinoembryonic antigen; CYFRA21-1: cytokeratin 19 fragments; CI: confidence interval.